Overview
Irritable bowel syndrome affects 10-15% of the global population, making it one of the most common functional gastrointestinal disorders. Characterized by abdominal pain, bloating, and altered bowel habits, IBS significantly impairs quality of life. Several supplements have demonstrated clinically meaningful symptom reduction in randomized controlled trials.

